Moreover, the highly predictable spread of hyperphosphorylated tau correlates better with cognitive decline than amyloid pathology [124,125], suggesting that tau may be the initiating agent for neurodegeneration in AD [126]. Here, MAPT is linked to Alzheimer disease.